BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21584847)

  • 1. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.
    Legnani C; Cini M; Cosmi B; Carraro P; Tripodi A; Erba N; Palareti G
    Intern Emerg Med; 2013 Apr; 8(3):229-36. PubMed ID: 21584847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
    Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A;
    Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the diagnosis of venous thromboembolism in emergency department.
    Mullier F; Vanpee D; Jamart J; Dubuc E; Bailly N; Douxfils J; Chatelain C; Dogné JM; Chatelain B
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):309-15. PubMed ID: 24247319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
    Rodger MA; Le Gal G; Langlois NJ; Gin B; Mallick R; Giulivi A; Freedman M; Kovacs MJ;
    Thromb Res; 2018 Sep; 169():82-86. PubMed ID: 30031290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-adjusted D-dimer cut-off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays.
    Farm M; Siddiqui AJ; Onelöv L; Järnberg I; Eintrei J; Maskovic F; Kallner A; Holmström M; Antovic JP
    J Thromb Haemost; 2018 May; 16(5):866-875. PubMed ID: 29505695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The performance of age-adjusted D-dimer cut-off in Chinese outpatients with suspected venous thromboembolism.
    Han C; Zhao Y; Cheng W; Yang J; Yuan J; Zheng Y; Yu X; Zhu T
    Thromb Res; 2015 Oct; 136(4):739-43. PubMed ID: 26254704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units.
    Cini M; Legnani C; Frascaro M; Sartori M; Cosmi B; Palareti G
    Int J Lab Hematol; 2014 Oct; 36(5):541-7. PubMed ID: 24428869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does age-adjusted D-Dimer have a role in assessment of VTE recurrence rates?
    Robertson C; Milne D; Watson H
    Int J Lab Hematol; 2020 Aug; 42(4):450-452. PubMed ID: 32359031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Harmonization of cut-off values of commercially available D-dimer tests].
    Török-Nagy B; Vajda Z; Vásárhelyi B
    Orv Hetil; 2019 Apr; 160(15):585-592. PubMed ID: 30957536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs.
    Park JK; Koo do H; Yoon DH; Lee JN
    Ann Vasc Surg; 2016 Jul; 34():119-34. PubMed ID: 27177705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive characteristics of D-dimer testing in outpatients with suspected venous thromboembolism: a Bayesian approach.
    Risch L; Monn A; Lüthy R; Honegger H; Huber AR
    Clin Chim Acta; 2004 Jul; 345(1-2):79-87. PubMed ID: 15193980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can an age-adjusted D-dimer level be adopted in managing venous thromboembolism in the emergency department? A retrospective cohort study.
    Jaconelli T; Eragat M; Crane S
    Eur J Emerg Med; 2018 Aug; 25(4):288-294. PubMed ID: 28079562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism.
    Legnani C; Cini M; Scarvelis D; Toulon P; Wu JR; Palareti G
    Thromb Res; 2010 May; 125(5):398-401. PubMed ID: 19683797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study.
    Palareti G; Legnani C; Cosmi B; Antonucci E; Erba N; Poli D; Testa S; Tosetto A; ;
    Int J Lab Hematol; 2016 Feb; 38(1):42-9. PubMed ID: 26362346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.
    Shi J; Ye J; Zhuang X; Cheng X; Fu R; Zhao A
    J Obstet Gynaecol Res; 2019 Mar; 45(3):657-664. PubMed ID: 30393982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
    Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
    Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Lemma L; Cosmi B; Palareti G; Chantarangkul V; Mannucci PM
    J Thromb Thrombolysis; 2010 Aug; 30(2):215-9. PubMed ID: 20419336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
    Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
    Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.